The human gastrointestinal tract contains a highly diverse community of microorganisms, including bacteria, archaea, fungi, and viruses.

Together, these microorganisms form the gut microbiome, which interacts continuously with intestinal and immune cells.

The gut microbiome contributes to nutrient metabolism, production of bioactive compounds, maintenance of intestinal barrier integrity, and regulation of immune responses.

Under healthy conditions, interactions between the host and its microbial community contribute to physiological balance.

Changes in microbial composition or function can disturb this balance.

Such alterations are often described as dysbiosis and have been associated with several human diseases.

Gut Microbiome and Human Health

Gut microorganisms perform numerous biological functions that influence the host.

They ferment dietary fibers and generate metabolites such as acetate, propionate, and butyrate.

These short-chain fatty acids can influence intestinal epithelial function, immune regulation, and energy metabolism.

Gut microorganisms also participate in bile acid metabolism and can produce or modify other metabolites with biological effects.

Consequently, changes in microbial activity can influence distant organs through microbial metabolites and immune signaling.

Major Types of Microbiome Alterations

Dysbiosis does not represent a single microbial pattern.

Different diseases may be associated with different changes in microbial diversity, abundance, and function.

Intestinal Barrier Dysfunction

The intestinal barrier prevents inappropriate movement of microorganisms and microbial products into the circulation.

It consists of epithelial cells, tight junctions, mucus, antimicrobial molecules, and immune components.

Dysbiosis may alter epithelial function and compromise barrier integrity.

Increased permeability can allow microbial components to reach underlying immune cells and the systemic circulation.

This may promote inflammatory signaling and contribute to systemic disease.

Gut Microbiome and Metabolic Diseases

Alterations in gut microbiota have been associated with obesity and type 2 diabetes.

Microbial metabolites can influence insulin sensitivity, energy metabolism, and appetite regulation.

Reduced production of beneficial short-chain fatty acids and changes in intestinal permeability may contribute to metabolic inflammation.

The microbiome may also influence bile acid signaling, which can affect glucose and lipid metabolism.

However, metabolic disease itself can alter the gut microbial environment, making the relationship bidirectional.

Gastrointestinal Diseases

The gut microbiome is directly involved in gastrointestinal health.

Changes in microbial composition and function have been investigated in inflammatory bowel disease, irritable bowel syndrome, colorectal cancer, and other gastrointestinal disorders.

Microbial metabolites can influence intestinal immune responses and epithelial integrity.

Some microbial communities may promote inflammatory signaling, whereas others may produce metabolites that support intestinal health.

Understanding these interactions may help identify new approaches to gastrointestinal disease management.

Gut Microbiome and Cardiovascular Disease

The gut microbiome can influence cardiovascular health through microbial metabolites and inflammatory pathways.

One extensively studied example is trimethylamine N-oxide, which is generated through microbial metabolism of dietary substrates.

Altered microbial metabolism may influence circulating metabolites associated with cardiovascular risk.

Chronic intestinal and systemic inflammation may also contribute to endothelial dysfunction and vascular disease.

These observations have increased interest in microbiome-derived metabolites as potential biomarkers.

Gut-Brain Interactions

The gut microbiome communicates with the nervous system through multiple pathways.

These include microbial metabolites, immune mediators, endocrine signaling, and neural pathways.

Changes in the gut microbial environment have been investigated in neurological and neuropsychiatric conditions.

Altered microbial metabolites may influence neuroinflammation and neurotransmitter-related pathways.

The gut-brain relationship is complex, and additional research is needed to determine the causal contribution of microbiome alterations to specific neurological diseases.

Gut Microbiome and Cancer

The gut microbiome may influence cancer development through inflammation, immune regulation, microbial metabolites, and interactions with epithelial cells.

Certain microorganisms have been investigated for their potential association with colorectal carcinogenesis.

The microbiome may also influence the effectiveness of some cancer treatments by modifying immune responses and drug metabolism.

Consequently, microbiome composition and function are increasingly being studied in cancer biology.

This article was prepared as a concise narrative review of scientific literature concerning alterations in the human gut microbiome and their association with disease.

Relevant research addressing dysbiosis, intestinal barrier function, microbial metabolites, inflammation, metabolic disease, gastrointestinal disorders, cardiovascular disease, neurological conditions, and cancer was considered.

The available evidence was synthesized to summarize the major mechanisms linking microbiome alterations with human disease.

Results

The reviewed evidence indicates that gut microbiome alterations are associated with multiple categories of human disease.

Changes in microbial diversity and microbial metabolism can influence intestinal barrier function, inflammation, immune responses, and host metabolism.

Dysbiosis has been reported in metabolic, gastrointestinal, cardiovascular, neurological, and malignant disorders.

However, microbial patterns vary considerably among diseases and populations.

This suggests that microbiome-associated disease mechanisms are highly context-dependent.

The gut microbiome represents an important biological interface between the environment and human physiology.

Diet, medications, age, genetics, lifestyle, and geographical factors can all influence microbial composition.

Because these factors also influence disease risk, it can be difficult to determine whether a specific microbial alteration is a cause, consequence, or modifier of disease.

Microbial metabolites provide an important mechanism for host-microbiome communication.

Short-chain fatty acids can influence immune function and epithelial health, whereas other metabolites may promote inflammatory or metabolic effects.

The intestinal barrier provides another important connection.

When barrier integrity is disrupted, microbial products can stimulate immune responses and contribute to systemic inflammation.

This may be relevant to diseases affecting organs outside the gastrointestinal tract.

Microbiome research also has potential clinical applications.

Microbial signatures may eventually be used to identify individuals at increased disease risk or monitor disease progression.

Therapeutic approaches such as dietary modification, probiotics, prebiotics, and microbiome transplantation are being investigated.

However, responses to these interventions vary considerably between individuals.

Future approaches will likely need to consider the functional characteristics of an individual's microbiome rather than simply increasing or decreasing particular bacterial species.

Potential Clinical Applications

Limitations and Future Perspectives

Several challenges currently limit routine clinical application of microbiome research.

There is substantial variation in microbial composition among healthy individuals.

Differences in diet, medication exposure, geographic location, sample collection, and sequencing methods can affect results.

Furthermore, microbial abundance does not always indicate microbial activity.

Future research should therefore integrate metagenomics with metabolomics, transcriptomics, proteomics, and host genetic information.

Large longitudinal studies will also be important for establishing causal relationships.

Development of standardized microbiome testing methods may eventually allow more reliable clinical applications.

Gut microbiome alterations are associated with a wide range of human diseases.

Dysbiosis can influence intestinal barrier integrity, immune responses, inflammation, microbial metabolism, and communication between the gut and distant organs.

These mechanisms may contribute to metabolic, gastrointestinal, cardiovascular, neurological, and malignant diseases.

Although microbiome-based diagnostics and therapies remain an emerging field, continued research may lead to new biomarkers and personalized therapeutic strategies.

A better understanding of host-microbiome interactions will be essential for translating microbiome research into effective clinical applications.

1. Thursby E, Juge N. Introduction to the human gut microbiota. Biochemical Journal. 2017;474:1823–1836.
2. Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. New England Journal of Medicine. 2016;375:2369–2379.
3. Marchesi JR, Adams DH, Fava F, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2016;65:330–339.
4. Sonnenburg JL, Bäckhed F. Diet–microbiota interactions as moderators of human metabolism. Nature. 2016;535:56–64.
5. Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165:1332–1345.
6. Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ. Dysbiosis of the gut microbiota in disease. Microbial Ecology in Health and Disease. 2015;26:26191.
7. Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E. Dysbiosis and the immune system. Nature Reviews Immunology. 2017;17:219–232.
8. Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nature Reviews Microbiology. 2021;19:55–71.
9. Garrett WS. Cancer and the microbiota. Science. 2015;348:80–86.
10. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature Reviews Neuroscience. 2012;13:701–712.